Skip to main content
. Author manuscript; available in PMC: 2021 May 10.
Published in final edited form as: J Control Release. 2020 Feb 12;321:363–371. doi: 10.1016/j.jconrel.2020.02.021

Figure 3.

Figure 3.

In vitro cytocompatibility and blood compatibility of GPUs. A) In vitro cyto-compatibility studies of GPUs observed over 80% viability of alveolar type-I cells via MTS assays. B) LIVE/DEAD cell viability assays also observed AT1 survival over 90% of AT1 survival at the highest NP concentration (* p< 0.05 vs. (+) control/complete media). C) GPUs observed low hemolysis (inset), and a blood clotting trend similar to that of saline control confirmed by the blood clotting profile.